CLPP and neoplasm: Through genetic and chemical approaches, multiple groups have identified the mitochondrial enzyme caseinolytic protease P (ClpP) as a direct target of ONC201 and demonstrated that ONC201-mediated ClpP activity is required for anti-tumor activity (75, 76).